![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Glochem Industries Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Cetirizine dihydrochloride, Unit II, Visakhapatnam, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2011-292 - Rev 00
This Chemical Type CEP, issued on February 09, 2017, remains in force until January 28, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 1084 associated with this CEP further emphasizes